Cargando…
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer
To evaluate the outcomes of total eradication therapy (TET), designed to eradicate all sites of visible cancer and micrometastases, in men with newly diagnosed oligometastatic prostate cancer (OMPCa). Men with ≤ 5 sites of metastases were enrolled in a prospective registry study, underwent neoadjuva...
Autores principales: | Reyes, D. K., Rowe, S. P., Schaeffer, E. M., Allaf, M. E., Ross, A. E., Pavlovich, C. P., Deville, C., Tran, P. T., Pienta, K. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286864/ https://www.ncbi.nlm.nih.gov/pubmed/32524295 http://dx.doi.org/10.1007/s12032-020-01385-7 |
Ejemplares similares
-
Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021) -
The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015) -
A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer
por: Ross, Ashley E., et al.
Publicado: (2019) -
CT‐based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration‐naïve oligometastatic prostate cancer
por: Sheikhbahaei, Sara, et al.
Publicado: (2020) -
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [(18)F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation
por: Shenderov, Eugene, et al.
Publicado: (2017)